Quantcast

Latest Acetylcholine Stories

2011-06-22 10:19:00

QUEBEC CITY, June 22, 2011 /PRNewswire/ -- Asmacure Ltee, a clinical-stage biopharmaceutical company focused on the development of nicotinic receptor agonists for the treatment of asthma and other inflammatory diseases, announced today that CEO Martin Driscoll will be presenting at the 2011 BIO Business Forum during the annual BIO International Convention. Mr. Driscoll's presentation will be given in the Georgetown Room of the Walter E. Washington Convention Center in Washington, DC on...

2011-05-16 14:21:04

Researchers in Baltimore have identified new compounds whichrelax airway muscles and may provide relief from shortness of breath for patients with COPD and asthma. The bitter-tasting compounds are at least as, if not more, effective than currently available agents used to manage these diseases, and may present new options for treatment. The study will be presented at the ATS 2011 International Conference in Denver. "We have identified compounds that are more potent than our previously...

2011-05-08 23:01:00

MADISON, Wis., May 9, 2011 /PRNewswire/ -- Mithridion, Inc., a privately-owned clinical stage drug development company focusing on serious Central Nervous System (CNS) disorders, announces that the U.S. Food and Drug Administration (FDA) has awarded Orphan Drug designation for MCD-386CR, its lead drug candidate, for the treatment of Progressive Supranuclear Palsy (PSP). Orphan status entitles Mithridion to seven years of market exclusivity upon approval of MCD-386 for treating PSP, and...

2011-04-18 10:56:00

NEW YORK, April 18, 2011 /PRNewswire/ -- What: The MG Walk is a new signature fundraising campaign designed to provide hope for the thousands of families forced to face the challenges caused by myasthenia gravis. On Saturday, April 30th, The MG Walk comes to Greenfield Park in West Allis, Milwaukee County in order to raise funds and awareness for the MGFA! This effort will raise funds to help us continue our mission to provide programs to assist those living with MG and fund research, in...

2011-04-08 07:00:00

MINNETONKA, Minn., April 8, 2011 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ:UPI) announced that NHIC Corp., the Medicare carrier for Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island and Vermont, will cover posterior tibial nerve stimulation (PTNS) using Uroplasty's Urgent® PC Neuromodulation System for the treatment of overactive bladder and associated symptoms, effective May 22, 2011. This decision adds approximately 1.8 million lives to those already covered...

2011-02-11 19:31:15

Newcastle University scientists have identified a new gene which will allow rapid diagnosis and earlier treatment of a debilitating neuromuscular condition. The gene, GFPT1, is crucial in causing a variation of Congenital Myasthenic Syndrome (CMS) which gained media attention recently with the plight of baby RB, who was at the centre of a "right-to-life" legal dispute. CMS is a rare genetic condition affecting the way signals travel between the brain and muscles which can cause paralysis and...

2011-01-24 15:34:18

Protection against nerve gas attack is a significant component of the defense system of many countries around the world. Nerve gases are used by armies and terrorist organizations, and constitute a threat to both the military and civilian populations, but existing drug solutions against them have limited efficiency. A multidisciplinary team of scientists at the Weizmann Institute of Science succeeded in developing an enzyme that breaks down such organophosphorus nerve agents efficiently...

2011-01-12 18:18:03

Millions affected by hearing disorder Targeted nerve stimulation could yield a long-term reversal of tinnitus, a debilitating hearing impairment affecting at least 10 percent of senior citizens and up to 40 percent of military veterans, according to an article posted in the Jan. 12 online edition of Nature. Researchers Dr. Michael Kilgard and Dr. Navzer Engineer from The University of Texas at Dallas and University-affiliated biotechnology firm MicroTransponder report that stimulation of the...

2011-01-11 05:00:00

MADISON, Wis. and TOLEDO, Ohio, Jan. 11, 2011 /PRNewswire/ -- Mithridion, Inc., a privately-owned clinical stage drug development company focusing on serious Central Nervous System disorders, including Alzheimer's disease, announces that it has secured commitments of $1.25 million in new funding. Venture Investors (VI - Madison, Wis.), The State of Wisconsin Investment Board (SWIB - Madison, Wis.), and Rocket Venture Fund (Toledo, Ohio) participated in the latest funding. "We plan to...

2010-12-09 07:46:38

(Ivanhoe Newswire) -- Medical researchers have found a so-called "missing link" that explains the interaction between brain state and the neural triggers responsible for learning. The good news : this may potentially opening up new ways of boosting cognitive function in the face of diseases such as Alzheimer's as well as enhancing memory in healthy people. Acetylcholine is released in the brain during learning and is critical for the acquisition of new memories. Its role is to facilitate the...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related